USA - NYSE:BAK - US1055321053 - ADR
ChartMill assigns a Buy % Consensus number of 51% to BAK. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-26 | UBS | Downgrade | Buy -> Neutral |
| 2025-08-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-09-18 | UBS | Upgrade | Neutral -> Buy |
| 2024-09-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-20 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-05-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-07-05 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-05-08 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2022-08-15 | ScotiaBank | Downgrade | Sector Perform -> Sector Underperform |
| 2022-01-26 | HSBC | Upgrade | Hold -> Buy |
| 2021-12-14 | Santander | Downgrade | Buy -> Hold |
| 2021-09-21 | B of A Securities | Reiterate | Buy |
15 analysts have analysed BAK and the average price target is 5.02 USD. This implies a price increase of 64.49% is expected in the next year compared to the current price of 3.05.
The consensus rating for BRASKEM SA-CLASS A- ADR (BAK) is 50.6667 / 100 . This indicates that analysts generally have a neutral outlook on the stock.